BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Levi Strauss
LEVI
$9.44B
| $44.7M | ﹤0.01% |
2,260,821
-839,926
| -27% | -$18.1M |
|
2652
Sumitomo Mitsui Financial
SMFG
$158B
| $44.6M | ﹤0.01% |
7,115,610
-92,527
| -1% | -$659K |
|
|
AMK
2653
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $44.5M | ﹤0.01% |
2,001,374
-72,758
| -4% | -$1.72M |
|
2654
Regional Management Corp
RM
$314M
| $44.3M | ﹤0.01% |
913,071
+23,053
| +3% | +$1.17M |
|
|
PARAP
2655
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
| $44.3M | ﹤0.01% |
797,552
-53,203
| -6% | -$3M |
|
2656
Gerdau
GGB
$9.97B
| $44.2M | ﹤0.01% |
8,657,179
+1,912,131
| +28% | +$8.21M |
|
|
AGEN
2657
Agenus
AGEN
$341M
| $44.2M | ﹤0.01% |
914,839
+15,588
| +2% | +$842K |
|
2658
Ducommun
DCO
$2.9B
| $44M | ﹤0.01% |
839,094
+28,819
| +4% | +$1.37M |
|
2659
Monte Rosa Therapeutics
GLUE
$1.36B
| $43.9M | ﹤0.01% |
3,128,392
+774,628
| +33% | +$10.8M |
|
2660
Barrett Business Services
BBSI
$985M
| $43.7M | ﹤0.01% |
2,258,204
+108,724
| +5% | +$1.84M |
|
2661
The RealReal
REAL
$1.53B
| $43.7M | ﹤0.01% |
6,015,234
+69,193
| +1% | +$612K |
|
2662
First Mid Bancshares
FMBH
$1.4B
| $43.6M | ﹤0.01% |
1,133,955
-27,634
| -2% | -$1.14M |
|
2663
Ryan Specialty Holdings
RYAN
$5.77B
| $43.4M | ﹤0.01% |
1,118,437
-3,161
| -0.3% | -$120K |
|
|
NGM
2664
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $43.3M | ﹤0.01% |
2,839,674
+58,883
| +2% | +$918K |
|
2665
Takeda Pharmaceutical
TAK
$52.9B
| $43.3M | ﹤0.01% |
3,021,274
+842,139
| +39% | +$12.4M |
|
|
ICPT
2666
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $43.2M | ﹤0.01% |
2,655,257
+423,165
| +19% | +$6.63M |
|
|
CCF
2667
DELISTED
Chase Corporation
CCF
| $43.2M | ﹤0.01% |
496,566
-7,241
| -1% | -$672K |
|
2668
Butterfly Network
BFLY
$2.36B
| $43.1M | ﹤0.01% |
9,045,958
+244,298
| +3% | +$1.34M |
|
|
RAD
2669
DELISTED
Rite Aid Corporation
RAD
| $43M | ﹤0.01% |
4,918,018
+257,634
| +6% | +$2.7M |
|
|
PYCR
2670
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $42.9M | ﹤0.01% |
1,474,969
+254,940
| +21% | +$6.79M |
|
2671
CALL
CSX Corp
CSX
$94.5B
| $42.8M | ﹤0.01% |
+1,142,500
| New | +$40.4M |
|
2672
Logitech
LOGI
$15.6B
| $42.7M | ﹤0.01% |
578,107
+93,104
| +19% | +$7.22M |
|
|
GOEV
2673
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $42.6M | ﹤0.01% |
16,786
+62
| +0.4% | +$170K |
|
2674
First Community Bankshares
FCBC
$922M
| $42.6M | ﹤0.01% |
1,509,222
-37,475
| -2% | -$1.15M |
|
|
VXRT
2675
DELISTED
Vaxart
VXRT
| $42.6M | ﹤0.01% |
8,442,629
-9,791
| -0.1% | -$49.6K |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.